Whereas obesity is a complex and multifactorial condition caused by genetic, environmental, behavioral, and other social determinants of health affecting both children and adults; Whereas obesity has reached epidemic proportions globally, contributing to a myriad of health issues and impacting the well-being of individuals; Whereas obesity is associated with an increased risk of developing coronary artery disease, hypertension, high LDL cholesterol, low LDL cholesterol, dyslipidemia, type 2 diabetes, chronic kidney disease, stroke, gallbladder disease, osteoarthritis, sleep apnea, cancer, mental illness, body pain, dementia, asthma, and over 200 others and other types of neurodivergent diseases, respiratory tract infections, and infertility and loss of pregnancy for women; Whereas the costs come from treating obesity and its associated comorbidities are increasing, it is estimated that the annual medical cost of obesity was nearly $173 billion dollars in 2019, while medical costs were found to be $1,861 higher for those with obesity compared to patients at a normal weight; Whereas the United States Government spends approximately $283 billion on obesity-related direct health costs in 2023, rising to $526.5 billion by 2033; Whereas the indirect costs of obesity on the economy are the productivity costs included and presenteeism, as well as premature mortality, loss of quality adjusted life years, and higher rates of disability benefit payments; Whereas obesity continues to have a strong impact on the global economy, the total costs of obesity are estimated to range from 0.05 percent to 2.24 percent of a country’s gross domestic product, and the World Obesity Federation estimates that the global economic impact of obesity will surpass $4 trillion by 2035; Whereas researchers have estimated that by 2030, if obesity trends continue unchecked, obesity-related medical costs alone could rise by $48 to $66 billion a year in the United States